Literature DB >> 10960177

Expression, purification and characterization of a functional region of the Plasmodium vivax Duffy binding protein.

S Dutta1, J R Daugherty, L A Ware, D E Lanar, C F Ockenhouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10960177     DOI： 10.1016/s0166-6851(00)00244-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  10 in total

1.  Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.

Authors:  Francis B Ntumngia; John H Adams
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

2.  Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.

Authors:  S Dutta; L A Ware; A Barbosa; C F Ockenhouse; D E Lanar
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.

Authors:  Francis B Ntumngia; Samantha J Barnes; Amy M McHenry; Miriam T George; Jesse Schloegel; John H Adams
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

4.  Duffy Blood Group System and the malaria adaptation process in humans.

Authors:  Gledson Barbosa de Carvalho; Glauber Barbosa de Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2011

5.  Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.

Authors:  A Moreno; I Caro-Aguilar; S S Yazdani; A R Shakri; S Lapp; E Strobert; H McClure; C E Chitnis; M R Galinski
Journal:  Vaccine       Date:  2008-06-23       Impact factor: 3.641

6.  Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.

Authors:  Francis B Ntumngia; Jesse Schloegel; Amy M McHenry; Samantha J Barnes; Miriam T George; Sandra Kennedy; John H Adams
Journal:  Vaccine       Date:  2013-07-31       Impact factor: 3.641

Review 7.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

8.  Easy and fast method for expression and native extraction of Plasmodium vivax Duffy binding protein fragments.

Authors:  Darwin Andrés Moreno-Pérez; Luis Alfredo Baquero; Maritza Bermúdez; Laura Alejandra Gómez-Muñoz; Yahson Varela; Manuel Alfonso Patarroyo
Journal:  Malar J       Date:  2018-02-08       Impact factor: 2.979

9.  Expression, Purification and Characterization of a Recombinant Plasmodium Vivax Thrombospondin Related Adhesive Protein (PvTRAP).

Authors:  Jamiu A Ogunbanwo; Prakash Rao Pendyala; Pawan Malhotra; Virander S Chauhan
Journal:  Int J Biomed Sci       Date:  2006-09

10.  Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates.

Authors:  Panita Gosi; Srisin Khusmith; Thareerat Khalambaheti; David E Lanar; Kurt E Schaecher; Mark M Fukuda; Scott R Miller
Journal:  Malar J       Date:  2008-06-26       Impact factor: 2.979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.